Hypoglycemia opens up new horizons Both Samols and Marks were interested in hypoglycaemia, a condition common among diabetics, patients with acute or chronic liver failure and a rare form of pancreatic tumour called 'insulinoma' which leads to the overproduction of insulin
The Challenge of Bioavailability While the science behind this combination is strong, there is a major hurdle: absorption
If you want a simple explainer on how that system works, read our All About Liposomes page
FDA regulatory context: As of May 2026, the FDA has proposed excluding compounded semaglutide and tirzepatide from the 503B Bulks List, with a public comment period closing June 29, 2026
Wegovy patient assistance program: How to afford your prescription If Wegovy is helping, cost shouldnt be the reason you have to stop
Market totals for telehealth GLP-1 range roughly $200 to $700+ monthly as of April 2026